Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Epirubicin, cyclophosphamide and docetaxel|DRUG: docetaxel, cyclophosphamide
Sponsor: Danish Breast Cancer Cooperative Group
Collaborators: Fonden Til Fremme af Klinisk- Eksperimentel Cancerforskning|Sanofi|Dako